by Cassie Arnold | Feb 9, 2021 | Biotech Finance, COVID, Deal making, Investment
If you had an inkling that more money went to vaccine and diagnostic companies in 2020, you were right. Diagnostics and vaccines have long been the red-headed stepchildren of life sciences investments. Detecting and treating life threatening diseases is the...
